Consumables Reagent purchase, Exclusion of restricted competition policy was stopped!

Medical Network June 12th, the Henan Province Puyang City Health Commission announced that the city's high value medical consumables, general medical supplies and in vitro diagnostic reagents for the procurement of distribution management changes, directly halted allegedly before Impede, limit competition terms.

At the end of last year, Xiangyang City had issued the “Notice on the Implementation of Purchasing Consumables for Procurement of Medical Consumables (for Trial Implementation)” (hereinafter referred to as “the old “Notice”) of the medical and health institutions in Xiangyang City, and decided to public medical institutions at and above the county level in the city. Fixed-point non-public medical institutions need all the medical supplies hanging net purchase.

The city decided to purchase medical supplies from the network. There are ten types of high-value consumables, as well as ordinary consumables, and in vitro diagnostic reagents.

It is worth noting that in the old “Notice”, the distribution management work for medical consumables was clearly defined as:

'Circulation companies must register and pay taxes in the area of ​​Fuyang City, and have fixed and qualified warehousing and logistics facilities within their jurisdiction. For enterprises that have signed strategic agreements with the municipal government, they shall provide support in accordance with relevant regulations.

The production company is the first person responsible for the quality and supply of medical consumables. It is possible to independently determine, maintain and change the distribution relationship of all consumable products of the company through the online trading platform of the centralized procurement of pharmaceuticals in Xiangyang City, ensuring timely and adequate supply of medical supplies within the city. Consumables to meet clinical needs. '

Recently, the Weiyang City Health and Family Planning Commission has issued the “Notice on Further Regulating the Purchase Work of the Medical Consumables of the City’s Medical and Health Institutions” (hereinafter referred to as “the new “Notice”), requesting that the city’s medical consumables be affixed from the date of issue. The net procurement work is carried out in accordance with the new "Notice", and the old "Notice" is also repealed.

The new “Notification” addresses the distribution management of medical consumables and clearly states:

'The production company is the first person responsible for the quality and supply of medical consumables. It can independently determine, maintain and change the distribution relationship of all consumable products of the company through the online transaction platform of the centralized procurement of pharmaceuticals in Xiangyang City, ensuring timely and adequate supply within the city. Medical consumables, to meet clinical needs. When distribution companies and distribution companies that have distribution relationships with distribution companies distribute their products, they should strictly comply with the relevant fiscal and taxation management requirements of the Xiangyang Municipal Government.

Compared with the old version of the "Notice", the new "Notice" abolished alleged discrimination against foreign circulation enterprises, aggravating the performance costs of foreign companies, impeding the content of fair competition in circulation companies.

This is also a typical case of a local government rectifying the procuring policy of drug and medical equipment suspected of excluding competitive restrictions.

From the end of last year to the present, many related cases have been published across the country. Among them:

Existing drug To select and distribute enterprises in a centralized manner, it is mandatory for the successful bidder to register a subsidiary locally within six months, or set up an unreasonable and discriminatory evaluation standard for local and foreign companies in the bid evaluation method;

There are also low-value consumables and testing reagents centralized procurement service organization selection, which requires successful registration companies within and outside the province within the past three years. proxy Bidding projects at or above the municipal level and providing online trading services;

There is also a local health care department that directs the distribution of pharmaceutical consumables to public medical institutions. enterprise , as the only distributor, or as a preferred supplier.

Since the second half of last year, the National Development and Reform Commission and other departments have also issued many documents to require the implementation and improvement of a fair competition review system to eliminate the introduction of policies that would prevent fair competition.

Among them, in December last year, the National Development and Reform Commission, the Ministry of Finance, and the Ministry of Commerce jointly issued a plan to decide on the use of one year to organize governments at all levels, and all departments should clean up the current competition and alleged exclusion of restrictive competition and competition measures. The repeal of this repeal, adjustment of the adjustment .

At the beginning of this year, the National Health and Family Planning Commission also sent a letter to solicit feedback on the contents of the committee's policies and measures that exclude exclusion of competition.

At the current stage, the anti-abuse administrative power excludes restricting competition. medicine Bidding The procurement field is one of the key points. With the explosion of one new case, it shows that the industry is anti-monopoly, unfair competition is far from over, and industry policy is still ongoing.